Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
NCT06830733
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Plasma Cell
Interventions
GENETIC:
ARI0002h
Sponsor
Fundacion Clinic per a la Recerca Biomédica